JPRN-UMIN000032157已完成未知
Detectability of breast lesions in the low-dose computed tomography - Detectability of breast lesions in the low-dose computed tomography
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •Examinees who have already received lung cancer screening on the same day.
研究者
相似试验
进行中（未招募）
1 期
Multihance versus Dotarem at 3 Teslathe aim of this study is to intraindividually compare the use of equivalent doses of gadobenate dimeglumine (MultiHance, Bracco Imaging, Milan, Italy) and gadoterate meglumine (DOTAREM, Guerbet, France) for breast MR imaging by using a prospective study design, evaluated independently by blinded readers.EUCTR2011-005498-21-ATMed. Univ. Wien, Univ. Klinik für Radiodiagnostik130
已完成
2 期
Detection of early premalignant breast lesions by autofluorescence ductoscopybreast cancerNL-OMON40131niversitair Medisch Centrum Utrecht30
已完成
不适用
on-invasive screening of the breast with the DELSENI with the DMS method.Mamma carcinoma10006291breast cancerNL-OMON46469Radboud Universitair Medisch Centrum10
已完成
不适用
Efficacy and safety of the breast biopsy marker (UltraClip) insertion in patients with breast cancer who undergo neoadjuvant chemotherapyBreast CancerJPRN-UMIN000027267Aichi Cancer Center Hospital Department of Breast oncology100
尚未招募
不适用
Tumorresponse monitoring in patients with breast cancer treated with primary systemic therapy: Towards predicting response in both the primary tumor and in axillary lymph nodescarcinoma10006291breast cancerNL-OMON31961Antoni van Leeuwenhoek Ziekenhuis300